These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34807396)

  • 1. Colistin induced acute kidney injury in critically ill children: a prospective study utilizing RIFLE criteria.
    Meysam S; Khosravi Z; Rashti R; Qorbani M; Assadi F; Hayatshahi A; Parin T; Faghihi T
    Daru; 2022 Jun; 30(1):11-15. PubMed ID: 34807396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study.
    Rocco M; Montini L; Alessandri E; Venditti M; Laderchi A; De Pascale G; Raponi G; Vitale M; Pietropaoli P; Antonelli M
    Crit Care; 2013 Aug; 17(4):R174. PubMed ID: 23945197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrotoxicity associated with intravenous colistin in critically ill patients.
    Doshi NM; Mount KL; Murphy CV
    Pharmacotherapy; 2011 Dec; 31(12):1257-64. PubMed ID: 22122186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study.
    Dalfino L; Puntillo F; Ondok MJ; Mosca A; Monno R; Coppolecchia S; Spada ML; Bruno F; Brienza N
    Clin Infect Dis; 2015 Dec; 61(12):1771-7. PubMed ID: 26354965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin nephrotoxicity in critically ill patients after implementation of a new dosing strategy.
    Ozel AS; Ergönül Ö; Korten V
    J Infect Dev Ctries; 2019 Oct; 13(10):877-885. PubMed ID: 32084017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury with intravenous colistin sulfate compared with polymyxin B in critically ill patients: A real-world, retrospective cohort study.
    Yang QJ; Xiang BX; Song MH; Yang CY; Liang JH; Xie YL; Zuo XC
    Pharmacotherapy; 2024 Aug; 44(8):631-641. PubMed ID: 39046197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colistin-induced Nephrotoxicity in a Tertiary Teaching Hospital.
    Al-Abdulkarim DA; Alzuwayed OA; Al Ammari M; Al Halwan S; Al Maklafi N; Thomas A
    Saudi J Kidney Dis Transpl; 2020; 31(5):1057-1061. PubMed ID: 33229769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine may reduce the risk of acute kidney injury development in critically ill patients during colistin therapy.
    Kucuk M; Heybeli C; Ozturk MC; Ergun B; Yakar MN; Gokmen AN; Comert B; Ergan B
    J Infect Chemother; 2023 Jul; 29(7):673-677. PubMed ID: 36921764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients.
    Gauthier TP; Wolowich WR; Reddy A; Cano E; Abbo L; Smith LB
    Antimicrob Agents Chemother; 2012 May; 56(5):2392-6. PubMed ID: 22371891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, risk factors and outcome of acute kidney injury in critically ill children - a developing country perspective.
    Rustagi RS; Arora K; Das RR; Pooni PA; Singh D
    Paediatr Int Child Health; 2017 Feb; 37(1):35-41. PubMed ID: 26752169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia.
    Omrani AS; Alfahad WA; Shoukri MM; Baadani AM; Aldalbahi S; Almitwazi AA; Albarrak AM
    Ann Clin Microbiol Antimicrob; 2015 Jan; 14():3. PubMed ID: 25591721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.
    Durante-Mangoni E; Andini R; Signoriello S; Cavezza G; Murino P; Buono S; De Cristofaro M; Taglialatela C; Bassetti M; Malacarne P; Petrosillo N; Corcione A; Viscoli C; Utili R; Gallo C
    Clin Microbiol Infect; 2016 Dec; 22(12):984-989. PubMed ID: 27545697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of a Colistin Loading Dose, High-Dose Maintenance Regimen in Critically Ill Patients With Multidrug-Resistant Gram-Negative Pneumonia.
    Elefritz JL; Bauer KA; Jones C; Mangino JE; Porter K; Murphy CV
    J Intensive Care Med; 2017 Sep; 32(8):487-493. PubMed ID: 27139010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin- and polymyxin-induced nephrotoxicity: focus on literature utilizing the RIFLE classification scheme of acute kidney injury.
    Pike M; Saltiel E
    J Pharm Pract; 2014 Dec; 27(6):554-61. PubMed ID: 25237156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity caused by colistin use in ICU: a single centre experience.
    Kilic I; Ayar Y; Ceylan İ; Kaya PK; Caliskan G
    BMC Nephrol; 2023 Oct; 24(1):302. PubMed ID: 37833622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colistin nephrotoxicity increases with age.
    Balkan II; Dogan M; Durdu B; Batirel A; Hakyemez IN; Cetin B; Karabay O; Gonen I; Ozkan AS; Uzun S; Demirkol ME; Akbas S; Kacmaz AB; Aras S; Mert A; Tabak F
    Scand J Infect Dis; 2014 Oct; 46(10):678-85. PubMed ID: 25073536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patients.
    Averbuch D; Horwitz E; Strahilevitz J; Stepensky P; Goldschmidt N; Gatt ME; Shapira MY; Resnick IB; Engelhard D
    Infection; 2013 Oct; 41(5):991-7. PubMed ID: 23653428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colistin nephrotoxicity in the ICU: Is it different in the geriatric patients?
    Aydoğan BB; Yıldırım F; Zerman A; Gönderen K; Türkoğlu M; Aygencel G
    Aging Clin Exp Res; 2018 Jun; 30(6):573-580. PubMed ID: 28866836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute kidney injury following colistin treatment in critically-ill patients: may glucocorticoids protect?
    Heybeli C; Canaslan K; Oktan MA; Yıldız S; Arda HÜ; Çavdar C; Çelik A; Gökmen N; Cömert B
    J Chemother; 2021 Apr; 33(2):85-94. PubMed ID: 32500843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Renal Toxicity of Colistin Therapy With Neutrophil Gelatinase-associated Lipocalin: a Biomarker of Renal Tubular Damage.
    Ordooei Javan A; Salamzadeh J; Shokouhi S; Sahraei Z
    Iran J Kidney Dis; 2017 Nov; 11(6):447-455. PubMed ID: 29190605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.